Author

M. Voysey

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.

BACKGROUND Immunisation in pregnancy against group B streptococcus could reduce severe disease in early infancy; however, there are few data on the safety and immunogenicity of vaccines given to women living with HIV and their infants. We aimed to evaluate the safety, tolerability, and immunogenicity of the hexavalent...

R. Mboizi, M. Sekikubo, G. Businge et al. · Lancet. Infectious Diseases... · 2 citations

Review Open access Aug 2026

8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.

BACKGROUND In low-income and middle-income countries, where typhoid fever remains a major public health problem, WHO recommends the use of typhoid conjugate vaccine (TCV). Here, we report vaccine effectiveness up to 8 years following a single dose of TCV in Nepal. METHODS TyVOID was a prospective cohort study that ex...

D. Pant, Yi-Yuan Zhang, F. W. Basile et al. · Lancet Global Health · 2 citations

Open access Jul 2026

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

Although no emergent safety signals were detected, continued post-marketing surveillance remains imperative, particularly for neurological disorders.

Narges Ebrahimi, P. D. de Whalley, Nasir Kanji et al. · Vaccine · 0 citations